In the spring of April 2025, Expomed Eurasia, a grand event attracting the attention of the global medical industry, will soon open in Istanbul. As a leader in the field of in vitro diagnostics (IVD) raw materials, Desheng New Materials will showcase its innovative product lineup at this exhibition (booth number: 829C5), aiming to exchange experiences and negotiate cooperation with global peers, and jointly promote the vigorous development of the medical industry.

Türkiye Medical Exhibition: a bright stage for global medical industry exchange

Expomed Türkiye Medical Exhibition is a very influential medical industry event in Europe, the Middle East and North Africa. This exhibition not only brings together medical equipment manufacturers, raw material suppliers, medical technology service providers, etc. from around the world, but also attracts the attention of numerous medical institutions, industry associations, and professionals.

Expomed Eurasia

The exhibition will be held in Istanbul from April 24 to 26, 2025. This city with unique geographical location is not only the economic and cultural center of Türkiye, but also an important hub connecting the East and the West. During the exhibition, Desheng New Materials will fully utilize this platform to showcase its innovative technologies and products, and collaborate with colleagues in the global medical industry to create a new chapter in industry development.

Desheng New Materials: Leading Industry Development with Technological Innovation

From 2005 to 2025, Desheng New Materials has written a history of progress in China's IVD raw materials in twenty years. The company is based in Ezhou, Hubei and has a production base covering an area of 5000 square meters. It has a professional R&D team of 30 people, with over 80% of them holding doctoral and master's degrees. It is precisely this persistence that has enabled Desheng to grow from a start-up enterprise to a high-tech enterprise with a complete industrial chain.

Desheng New Materials always adheres to the concept of "craftsmanship, quality, innovation driven", and is committed to providing customers with high-performance, low-cost, and domestically produced core raw materials. After 20 years of technological accumulation and market refinement, the company has developed into a high-tech enterprise that integrates research and development, production, sales, and service throughout the entire industry chain.

Five core product series unveiled at the exhibition site

At this exhibition, Desheng New Materials will showcase its five core product lines, including chemiluminescence series, biological buffer series, chromogenic substrate series, enzyme preparations, and antigen antibodies. These products are widely used in fields such as biochemical analysis, immune testing, molecular diagnostics, etc., providing stable and reliable raw material support for global customers.

Chemiluminescence series: providing highly sensitive chemiluminescence immunoassay core materials, suitable for high-precision requirements such as tumor markers and infectious diseases.

Biological buffer series: purity over 99.9%, batch difference less than 1%, widely used in PCR, gene sequencing, cell culture and other fields.

Color substrate series: fast color development speed, low background value, supports customized formulas, and meets the needs of fully automatic biochemical analyzers and POCT equipment.

Enzyme preparations: high activity, high purity, and stability, covering various testing items such as cardiovascular markers, infectious disease screening, tumor diagnosis, etc.

Antigen antibody: There are up to a hundred types of products with high specificity and sensitivity, which can be used in fields such as immunology research, protein research, and disease diagnosis.

Seeking common development and jointly creating the future

On the stage of Türkiye Medical Exhibition Expomed Eurasia, Desheng New Materials looks forward to in-depth exchanges with colleagues in the global medical industry, to jointly discuss the development trend of the industry, and to share technological innovation achievements. We sincerely invite all allies to visit our booth (829C5) to explore the future of medical technology and work together to create a better tomorrow.